EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Enhancing thrombolytic therapy in Japan-dwelling Japanese using clinical ultrasound with microbubble contrast agent

Takako Shirakawa, Tsutomu Matsuura, Norio Sekine, Hiroyuki Takahashi, Hirotaka James Okano, Takao Ohki, Kentaro Kasa, Yoshitaka Mine, Tomoyuki Ohta

Journal of Medical Ultrasonics · 2026

DOI: 10.1007/s10396-026-01620-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Ultrasonics, 2026. Verfasst von Takako Shirakawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Human Health Sciences, Tokyo Metropolitan University, 7-2-10 Higashi-Ogu, Arakawa, Tokyo, 116-8551, Japan. t-shirakawa@tmu.ac.jp. Hauptthemen laut MEDLINE: Microbubbles, Thrombolytic Therapy, Contrast Media, Ferric Compounds. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Tokyo Metropolitan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To determine in vitro the efficacy and safety of thrombolysis in blood from Japanese subjects using standard diagnostic ultrasound (US) with or without microbubbles. METHODS: Blood from six healthy Japan-dwelling Japanese (mean age 22.3 years), who have relatively low susceptibility to thrombosis because of heredity and dietary habits, was left at room temperature for 24 or 72 h. Each clot-containing well was submerged in a 150-mL heparin-physiologic saline bath (5 units heparin/mL) and rotated at 180 rpm. The 30-min US treatment conditions were: (1) no US or microbubbles; (2) grayscale US (4.5 MHz); (3) color Doppler; (4) grayscale US with addition of 4-μL perflubutane microbubbles (Sonazoid; GE Healthcare Pharma Corporation, Tokyo Japan) to the bath every 5 min; and (5) color Doppler with microbubble addition as above. The Aplio i800 (Canon Medical Systems, Tochigi Japan) US system was used with the i8CX1 transducer. RESULTS: Among six subjects with clots, the number of 24-h clots that changed to hypoechoic under each condition was as follows: (1) 0, (2) 3, (3) 5, (4) 6, and (5) 5. For 72-h clots, the number of changes was: (1) 0, (2) 1, (3) 3, (4) 6, and (5) 3. In Masson's trichrome-stained specimens, US treatment generated less fibrin within the light-blue amorphous element than in the control. No rupture of red blood cells was observed. CONCLUSION: We confirmed that standard clinical diagnostic US, used for grayscale or color Doppler imaging, enhanced thrombolysis. Thrombolytic efficacy was greater with combination of Sonazoid and US than with US alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobubblesThrombolytic TherapyContrast MediaFerric CompoundsThrombosisIronOxidesHumansJapanMaleFemaleYoung AdultAdultUltrasonography, Doppler, ColorUltrasonographyEast Asian People

Stichwörter der Autor:innen

MicrobubbleThrombolysisUltrasound

Substanzen

Contrast MediaSonazoidFerric CompoundsIronOxides

Autor:innen und Institutionen

  • Graduate School of Human Health Sciences, Tokyo Metropolitan University, 7-2-10 Higashi-Ogu, Arakawa, Tokyo, 116-8551, Japan. t-shirakawa@tmu.ac.jp.
  • Graduate School of Human Health Sciences, Tokyo Metropolitan University, 7-2-10 Higashi-Ogu, Arakawa, Tokyo, 116-8551, Japan.
  • Department of Histology, The Jikei University School of Medicine, Minato-Ku, Tokyo, Japan.
  • Division of Regenerative Medicine, The Jikei University School of Medicine, Minato-Ku, Tokyo, Japan.
  • Department of Surgery, The Jikei University School of Medicine, Minato-Ku, Tokyo, Japan.
  • Department of Radiology, International University of Health and Welfare, Otawara City, Tochigi, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Tokyo Metropolitan University

Zitieren

APA

Shirakawa, T., Matsuura, T., Sekine, N., Takahashi, H., Okano, H. J., Ohki, T., Kasa, K., Mine, Y., & Ohta, T. (2026). Enhancing thrombolytic therapy in Japan-dwelling Japanese using clinical ultrasound with microbubble contrast agent. Journal of Medical Ultrasonics. https://doi.org/10.1007/s10396-026-01620-0

Vancouver

Shirakawa T, Matsuura T, Sekine N, Takahashi H, Okano HJ, Ohki T, et al. Enhancing thrombolytic therapy in Japan-dwelling Japanese using clinical ultrasound with microbubble contrast agent. Journal of Medical Ultrasonics. 2026. doi:10.1007/s10396-026-01620-0

BibTeX
@article{Shirakawa2026,
  author = {Shirakawa, Takako and Matsuura, Tsutomu and Sekine, Norio and Takahashi, Hiroyuki and Okano, Hirotaka James and Ohki, Takao and Kasa, Kentaro and Mine, Yoshitaka and Ohta, Tomoyuki},
  title = {Enhancing thrombolytic therapy in Japan-dwelling Japanese using clinical ultrasound with microbubble contrast agent},
  journal = {Journal of Medical Ultrasonics},
  year = {2026},
  doi = {10.1007/s10396-026-01620-0}
}
Kostenlos starten →